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Essentials
• Genetic variation may provide valuable insight into the role of the contact system in thrombosis.
• Explored associations of genetic variants with activity, antigen, and disease in RATIO study.
• Two novel loci were identified: KLKB1 rs4253243 for prekallikrein; KNG1 rs5029980 for HMWK levels.
• Contact system variants and haplotypes were not associated with myocardial infarction or stroke.
Summary. Background: The complex, interdependent contact activation system has been implicated in thrombotic disease, although few genetic determinants of levels of proteins from this system are known. Objectives: Our primary aim was to study the influence of common F11, F12, KLKB1, and KNG1 variants on factor (F) XI activity and FXI, FXII, prekallikrein (PK) and high-molecular-weight kininogen (HMWK) antigen levels, as well as the risk of myocardial infarction and ischemic stroke. Patients/methods: We analyzed samples from all 630 healthy participants, 182 ischemic stroke patients and 216 myocardial infarction patients in the RATIO case-control study of women aged < 50 years. Forty-three tagging single nucleotide variants (SNVs) were genotyped to represent common genetic variation in the contact system genes. Antigen and activity levels were measured with sandwich-ELISA-based and one-stage clotting assays. We performed single variant, age-adjusted, linear regression analyses per trait and disease phenotype, assuming additive inheritance and determined conditionally independent associations. Haplotypes based on the lead SNV and all conditionally independent SNVs were tested for association with traits and disease. Results: We identified two novel associations of KLKB1 SNV rs4253243 with PK antigen (b conditional = À12.38; 95% CI, À20.07 to À4.69) and KNG1 SNV rs5029980 with HMWK antigen (b conditional = 5.86; 95% CI, 2.40-9.32) and replicated previously reported associations in a single study. Further analyses probed whether the observed associations were indicative of linkage, pleiotropic effects or mediation. No individual SNVs or haplotypes were associated with the disease outcomes. Conclusion: This study adds to current
Introduction
The contact activation system, upstream in the intrinsic coagulation pathway, plays an important but until recently underappreciated role in pathological thrombus formation [1] [2] [3] [4] . This system's numerous interdependencies make it complex: upon binding to a negatively charged surface, coagulation factor XII (FXII) is activated, which in turn activates factor XI (FXI), triggering the downstream procoagulant intrinsic coagulation cascade [5, 6] . Simultaneously, FXIIa sets the proinflammatory kinin-kallikrein system into motion by activating prekallikrein (PK) to kallikrein, which in turn cleaves high-molecular-weight kininogen (HMWK) into bradykinin [7] . Non-enzymatic HMWK molecules serve as a cofactor in the activation of both FXI and PK, for example by anchoring FXI and PK to neutrophil membranes [6, 8] .
High plasma levels of contact system factors, especially FXI, contribute to a hypercoagulable state and have been associated with increased risk of venous [9] [10] [11] [12] and arterial thrombosis [13] [14] [15] [16] . Several genetic variants of these factors have also been implicated in thrombotic diseases, but their means of exerting influence often remain unclear [17] [18] [19] [20] [21] [22] . A considerable amount of variation in both activity and antigen levels of these coagulation factors in healthy individuals can be attributed to genetic variation, with heritability estimates of 67% for FXII levels and 45% for FXI [23] . Effects of single nucleotide variants (SNVs) in F12 (chromosome(chr) 5) and F11 genes (chr 4) on circulating levels of FXII and FXI activity and antigen, respectively, have previously been explored [24] [25] [26] . Less is known about the influence of genetic variation in KLKB1 (kallikrein B1, chr 4) on PK levels and in KNG1 (chr 3) on HMWK levels, apart from recent protein genome-wide association study (GWAS) findings [27] . Furthermore, some across-trait associations within the contact system are known. Recent studies have shown associations of KNG1 SNVs with FXI levels [25, 26] , as well as KLKB1 and KNG1 SNVs with PK and HMWK levels [27, 28] . Although generally less well studied, these may provide valuable insights into regulatory mechanisms.
In this study, we explore associations between genetic variation in F12, F11, KLKB1 and KNG1 and FXII, FXI, PK and HMWK levels via tagging SNVs as well as haplotype analyses. We additionally explore whether this genetic variation, especially in haplotype combinations, is associated with ischemic stroke (IS) and myocardial infarction (MI) in young female Dutch RATIO study participants.
Materials and methods

Study design and participants
The Risk of Arterial Thrombosis In relation to Oral contraceptives (RATIO) multicenter, population-based, case-control study has been previously described in detail [29] [30] [31] . Briefly, the first phase of the study assessed risk factors for MI and IS in young women aged 18-50 years. Cases were recruited from 16 participating hospitals in the Netherlands between 1990 and 1995. Control women with no history of arterial thrombosis were recruited using random digit dialing and frequency matched on age, calendar year of the event and area of residence. Blood samples and buccal swabs were collected in a second phase (1998) (1999) (2000) (2001) (2002) and DNA was harvested and stored for later analyses. All RATIO study participants provided written informed consent and the ethics committees of the participating hospitals approved the study.
SNV selection and genotyping
For each of the genes, using HapMap reference data from the CEU population (build GRCh37), tag SNVs were selected using Haploview software (version 4.2) [32] based on standard settings and a minor allele frequency (MAF) of > 5% and r 2 > 0.80. Gene boundaries were not extended. Complete tagger results are reported in Table S1A . In total, 43 SNVs, two in F12, 11 in F11, 10 in KLKB1 and 20 in KNG1, were selected to represent common genetic variation in these genes.
Genotyping was performed by technicians who were blinded to the case/control status of the participants using KASPar SNP genotyping assays according to the manufacturer's instructions (KBioscience, Hoddesdon, UK). Because of failures in assay design, for three SNVs, TaqMan genotyping assays were used (Thermo Fisher Scientific, Waltham, MA, USA). Assay design failed again for KNG1 SNV rs5030072 and thus this SNV was not analyzed. The average call rate per SNV in control subjects with DNA available (n = 755) was 94.3%, and KNG1 SNV rs266723 had the lowest call rate (90.5%) of all SNVs assayed (Table S1B) .
Contact system protein measurements
Blood samples were obtained from 638 control subjects 5 years after the index date, on average. Antigen levels of FXI, PK, HMWK and FXII (FXI:ag, PK:ag, HWMK:ag and FXII:ag) were measured using sandwich ELISAbased assays with polyclonal antibodies in duplicate and expressed as percentages of normal pooled plasma, as previously described [15, 33] . Inter-assay coefficients of variation were 9.3%, 4.9%, 9.2% and 12.0%, respectively. FXI activity (FXI:C) was additionally measured in duplicate in MI patients and control subjects using a onestage clotting assay and FXI-deficient plasma, with a coefficient of variation < 10%, as detailed elsewhere [34] .
Statistical analyses
Study population characteristics were summarized using mean and median values (with standard deviations or ranges) or absolute numbers and percentages, as appropriate. Antigen and activity measurements were normally distributed and did not require transformation. Departures from the Hardy-Weinberg equilibrium were tested using v 2 goodness-of-fit tests with a continuity correction or exact tests if expected counts were below five (Table S1B) .
To investigate associations between SNVs and the five traits, we performed single variant analyses in control subjects only using age-adjusted linear regression models. An additive model of inheritance was assumed in all quantitative trait loci (QTL) analyses to investigate the change in respective contact system factor level per copy of the minor allele (b) to maximize power. To account for multiple testing, we used a Bonferroni-corrected overall significance level of 0.00116 based on the total number of variants tested per trait (n = 43).
When multiple variants within one gene were associated with the same trait, we performed conditional regression analyses to identify associations conditionally independent of the lead SNV. SNVs with persisting associations were mutually adjusted and only remaining contributing signals were carried forward to the haplotype analyses with the lead SNV. To assess associations between SNVs and other traits, we first adjusted for the levels of the encoding gene's trait. IBM SPSS Statistics v23 was used for all variant association analyses.
We constructed haplotypes for each gene, including the lead SNV and any secondary signals. We used the haplo.em function of the haplo.stats R package to estimate haplotypes per gene for each individual, accounting for the unphased nature of our data, and the haplo.glm function to run age-adjusted regressions for all haplotypes with a frequency > 1% in control subjects [35] . For each gene, the haplotype containing major allele copies was used as a reference and effect size (b), standard error (SE) and P-value estimates were calculated for the other inherited combinations.
All variants associated with at least one of the traits following conditional analysis as well as the previously constructed haplotypes were additionally tested for association with risk of MI and IS using logistic regression models, assuming an additive mode of inheritance. We adjusted these models for the matching variables including age, area of residence and index year.
Results
In total, 767 controls, 218 MI patients and 190 IS patients (including 50 additional IS patients) entered the second phase of the RATIO study. As shown in Fig. 1 , 755 control subjects, 216 MI patients and 182 IS patients with at least one SNV call were included in the variantdisease association analyses. Only control subjects with DNA and blood plasma samples were included in the protein QTL analyses (n = 630). Control subjects' baseline characteristics are displayed in Table 1 (MI and IS patients' characteristics in Table S2 ).
Quantitative trait associations
F11 variation Five of the 11 F11 SNVs showed associations with FXI activity below the Bonferroni-corrected threshold (Table 2 ; remainder in Table S3 ). Lead SNV rs4253399 was associated with an increase in FXI:C of 9.24 units (95% confidence interval [CI], 6.69-11.79; P = 3.32 9 10
À12
; MAF = 38.9%) per minor allele (G) copy, measured as percentage of activated normal pooled plasma, explaining 7.8% of the total variance in FXI:C. SNV rs4253399 is in relatively high linkage disequilibrium (LD) (r 2 = 0.77) with rs2289252 in 1000Genomes data of Europeans, which has been associated with FXI:ag [18] , FXI:C and activated partial thromboplastin time (APTT) [36] . Table 3 shows association results conditional on the lead SNV rs4253399. Of the three remaining associations with FXI:C, the strongest was with rs1593 (b conditional = À5.65; 95% CI, À9.46 to À1.83; Pconditional = 0.004; MAF = 12.2%), previously associated with APTT [37] . Furthermore, rs4253421, tagged by rs1593, was associated with a decrease in FXI antigen/activity levels in a pooled GWAS [26] . Additional adjustment for rs1593 diminished remaining associations.
Four of the F11 SNVs significantly associated with FXI activity as well as rs4253430 were associated with FXI antigen ( Table 2 ). The lead SNV rs2036914 (b = À11.38; 95% CI, À14.18 to À8.58; P = 7.87 9 10
À15
; MAF = 46.3%) explained 9.1% of variance in FXI:ag. SNV rs2036914 has been shown to be associated with FXI:ag [18] , FXI:C and prolonged APTT [36] , and tagged rs4241824, which has been associated with FXI:ag [12, 25] . After conditioning on the lead SNV, two associations with FXI:ag remained: rs1593 and rs4253399, the same two SNVs from the FXI:C trait analyses. Both signals remained after additional mutual adjustment (rs1593: b = À7.47; 95% CI, À11.99 to À2.96; P = 0.001; rs4253399: b = 6.11; 95% CI, 2.02-10.20; P = 0.003).
All F11 SNVs were additionally tested for associations with the other three traits: PK:ag, HMWK:ag and FXII: ag (Table S4) ; only rs4253406 showed suggestive evidence of an association with PK:ag.
Overall, the effect sizes observed for associations between F11 SNVs and FXI:ag were larger in magnitude than those for FXI:C. Exploratory analyses shown in Table 4 indicate the majority of the associations with FXI:C were greatly attenuated upon adjustment for antigen levels. Although the association between rs4253399 and FXI:C diminished upon adjustment for FXI:ag, a conditional association not explained by FXI:ag (b adjusted = 3.07; 95% CI, 0.95-5.20; P adjusted = 0.005) remained. Reciprocal adjustment of the association with FXI:ag for FXI:C resulted in a modest effect size reduction.
KLKB1 variation Six of the 10 KLKB1 SNVs tested showed below-threshold associations with PK:ag, with effect size magnitudes ranging from 6.55 to 16.93 (Table 2 ; above-threshold associations in Table S3 ). Lead variant rs2304595 (b = 10.33; 95% CI, 6.65-14.02; P = 5.58 9 10 À8 ; MAF = 43.2%) explained 5.1% of the total variance in PK:ag and tagged rs1511802, previously reported to be associated with PK levels [27] . SNV rs4253243 had the largest effect size of all KLKB1 SNVs tested; after conditioning on rs2304595, it was the only remaining association with PK:ag (b conditional = À12.38; 95% CI, À20.07 to À4.69; P conditional = 0.0017) and is a novel finding (Table 3) . Three KLKB1 SNVs, rs1511801, rs2304595 and rs3087505, showed significant associations with both FXI: C and FXI:ag in single variant analyses (Table S4) . After adjustment for PK:ag or lead F11 SNV rs2036914, the associations between KLKB1 SNVs rs1511801 and rs2304595 and both FXI:C and FXI:ag were reduced (Table 4) , indicating the observed effects could be explained by linkage between KLKB1 and F11 SNVs (e.g. pairwise LD of rs1511801 and rs2036914; r 2 = 0.41; D 0 = 0.64). The associations between rs3087505 and the two FXI traits were not affected by the adjustment for PK: ag; however, adjustment for F11 SNV rs2036914 attenuated these associations considerably, whereas adjustment for rs1593, an F11 SNV in moderate LD with rs3087505 (r 2 = 0.71, D 0 = 1.00), diminished them entirely.
KNG1 variation Eleven of the 20 KNG1 SNVs had significant single variant associations with HMWK:ag ( Table 2 , non-significant results in Table S3 ). Lead SNV rs5030062 was strongly associated with HMWK:ag (b = 10.23; 95% CI, 7.87-12.59; P = 1.63 9 10
À16
; MAF = 38.3%) and explained 10.9% of the variance in HMWK:ag. This confirms a reported association of a tagged SNV rs3856930 with HMWK levels [27] . After adjustment for the lead SNV, eight associations remained (Table 3) , the strongest of which was with rs2304456 (b conditional = À7.96; 95% CI, À11.60 to À4.32; P conditional = 2.1 9 10
À5
; MAF = 11.4%), recently described in the literature [27] . Additionally, a novel association between rs5029980 and HMWK:ag remained after adjustment for both rs5030062 and rs2304456 (b indepedent = 5.86; 95% CI, 2.40-9.32; P indepedent = 0.001). All other associations were attenuated.
Two KNG1 SNVs (rs5030062 and rs5030060) showed across-trait associations with PK:ag, and four KNG1 SNVs (rs5030062, rs5030060, rs1469859 and rs166479) showed associations with FXI:C (Table S4) addition to FXI:C, rs5030062 was associated with FXI:ag after conditioning on FXI:C. This SNV as well as a tagged missense variant rs710446 have been associated with FXI levels in both pooled activity/antigen GWAS and activity-only analyses [25] [26] [27] 38] . We investigated whether the associations between KNG1 SNVs and the other contact system traits are a result of pleiotropy, when a single gene exerts an effect on multiple traits, or can be explained by a potentially mediating effect via HMWK. These exploratory analyses revealed that the association between rs5030062 and FXI:C remained after adjustment for HMWK:ag and FXI:ag, unlike the association of rs5030062 with FXI:ag, which was greatly reduced following adjustment for either HMWK:ag or FXI:C (Table 4 ). The replicated association between rs5030062 and PK:ag [27] disappeared following adjustment for HMWK:ag and was greatly reduced upon adjustment for FXI levels. The association between rs5030062 and HMWK:ag was only slightly reduced following adjustment for FXI:C and FXI:ag.
F12 variation Both rs1801020 (lead SNV) and rs17876032 have been associated with FXII:ag in previous studies [24, 39] , and rs1801020 with APTT [40] . Each showed strong associations with FXII:ag: b = À41.54 (95% CI, À45.67 to À37.41; P = 6.85 9 10 À67 ; MAF = 25.3%) and b = À28.09 (95% CI, À32.52 to À23.66; P = 1.42 9 10
À31
; MAF = 34.9%) ( Table 2) . SNV rs1801020 explained 39.5% of the variance in FXII:ag, the largest of the five traits analyzed. No conditional effect of rs17876032 in non-carriers of rs1801020 was observed following adjustment (Table 3) . Neither F12 variant showed associations with the other traits (Table S4) .
To address the potential issue of confounding as a result of population admixture, we additionally adjusted the analyses of the lead variants for ethnicity in a sensitivity analysis and observed no meaningful differences in the results ( S5).
Haplotype analyses
Using the haplo.em function, haplotypes with frequencies of at least 1% in control subjects were constructed from various combinations of the lead and conditionally independent SNVs for each gene.
F11
The lead SNVs from both FXI traits (rs4253399 and rs2036914) and rs1593, a third SNV associated with both traits after conditioning for the other two, were included in the constructed F11 haplotypes (Table 5) . Haplotype 4, containing at least one copy of the rs4253399 major allele (T), the rs2036914 minor allele (T) and the rs1593 minor allele (T), was associated with a substantial decrease in FXI:ag (b = À12.9; SE = 2.8; P < 0.0001) compared with the reference haplotype containing all major alleles. The haplotypes were then tested for association with FXI:C; a moderate association was observed for Haplotype 4 (b = À7.7; SE = 2.5; P = 0.002; Table S6 ).
KLKB1
Our results revealed that the minor alleles of the two KLKB1 SNVs with conditional effects did not occur in an inherited combination in our study population (Table S6) , which is likely to be attributable to low linkage (r 2 = 0.046; D 0 = 1.00).
KNG1 Five haplotypes were constructed from the three conditionally independent KNG1 SNVs. Compared with the reference haplotype, Haplotype 5, having at least one copy of minor alleles of rs5029980 (C) and rs5030062 (C), which occurred in 4.4% of control subjects, was associated with a 25.2 unit increase in HMWK:ag in control subjects (SE = 3.4; P < 0.0001).
F12
No haplotypes were generated for F12 because no secondary associations remained after adjustment for the lead F12 SNV (rs1801020).
Associations with IS and MI
None of the 26 SNVs, each significantly associated with levels of the respective protein for which the gene encodes, showed single variant associations with either IS or MI (Table S7 ). The previously described haplotypes were also tested for associations with IS and MI in cases and controls adjusted for matching variables (Table S8) b coefficients representing the change in contact system trait level per copy of the minor allele were calculated from linear regression using an additive model adjusted for age. A significance level of 0.00116 was used based on a Bonferroni correction for 43 tests. Only significant associations between variants and the levels for which the gene is coding are shown here. Variants are ordered by level of statistical significance. A1 indicates major allele; A2, minor allele; Chr. position, chromosomal position (build GRCh37); CI, confidence interval; PK, prekallikrein; HMWK, high-molecular-weight kininogen; MAF, minor allele frequency in control subjects; SNV, single nucleotide variant. *Measured as a percentage of activated normal pooled plasma. †Measured as a percentage of normal pooled plasma.
(OR IS = 1.08, 95% CI, 0.53-2.23; OR MI = 1.00, 95% CI, 0.46-2.21).
Discussion
In this study, we assessed relationships between tagging SNVs representing common genetic variation in the four contact system genes and protein levels of each factor in a single homogenous population. We identified KLKB1 SNV rs4253243 and KNG1 SNV rs5029980 as novel loci for PK:ag and HMWK:ag, respectively, and confirmed across-trait associations between KNG1 variants and FXI levels, which can only in part be explained by HMWK:ag. We determined that many previously described across-trait associations can largely be explained by coinheritance of variants and potentially mediating effects via trait levels. b coefficients were calculated from linear regression using an additive model adjusted for age and the additional adjustment factor indicated in each column. CI, confidence interval; PK, prekallikrein; SNV, single nucleotide variant; HMWK, high-molecular-weight kininogen.
*Measured as a percentage of normal pooled plasma. †Measured as a percentage of activated normal pooled plasma.
Additionally, we probed the influence of these variants in inherited combinations as well as their potential roles in IS and MI. Our study design provided the unique opportunity to assess whether variants were associated with FXI:C, FXI:ag or both, and whether these associations persisted after mutual adjustment. This distinction is rarely possible in smaller-scope studies or larger GWAS analyses, because activity and antigen levels are often studied in isolation or are pooled.
In the present study, three of 11 tested variants were found to have persistent associations with FXI:C or FXI:ag. SNV rs1593 tagged rs4253421, an intronic SNV classified as a genic enhancer [41] , which was associated with pooled FXI levels in a recent GWAS [26] . The observed association between rs1593 and FXI:C disappeared after adjustment for antigen levels. This suggests the effect of this SNV (or a tagged SNV) influences FXI:C via its effect on FXI:ag (i.e. it has a quantitative rather than qualitative effect on the protein). Similar results were observed for F11 SNV rs2036914, which is an expression quantitative trait locus (eQTL) for F11 in lung tissue [42] . Results of our explanatory analyses clarified that the observed associations of rs2036914 and rs1593 with FXI activity can be completely explained by their associations with FXI:ag. We found that rs4253399 has a direct association with FXI:C not explained by FXI:ag.
In KLKB1, we found a strong association between lead SNV rs2304595 and PK:ag. SNV rs2304595 is an eQTL for F11 and CYP4V2 in several tissues but is not associated with KLKB1 expression [42] . This association may be a result of the proximity of the KLKB1 and F11 genes, especially because an association with FXI levels was observed; however, to better understand this relationship, a formal mediation analysis is warranted, for which this study lacks the statistical power. Of the 10 variants tested, one additional novel association with rs4253243 remained associated with PK:ag after adjustment. SNV rs4253243 is an eQTL for KLKB1 in lung, heart (atrial appendage) and nerve (tibia) tissue and as well for F11 in brain tissue [42] .
In KNG1, we confirmed two recently identified associations of rs5030062 and rs2304456 with HMWK:ag and found an additional novel association with rs5029980.
We did not observe much common variation in F12 that influenced FXI:ag levels; only two SNVs, rs17876032 and rs1801020, captured the common variation in this gene. F12 is the smallest of the four contact system genes analyzed, and this may explain the limited common variation. Interestingly, upon interrogation, only rs1801020 remained associated with FXII:ag. SNV rs1801020, a frequently occurring C->T polymorphism in the F12 promoter region, was the top SNV in a previous FXII study and has been reported as an eQTL for F12 in liver tissue [24, 42] .
Multiple associations were observed between F11 and KLKB1 SNVs and FXI:C, FXI:ag and PK:ag phenotypes. Our exploratory analyses demonstrated these observations can largely be explained by the close proximity of these genes (about seven kilobase pairs; see regional association plots in Figures S1-S3) . We also observed associations between KNG1 SNV rs5030062 and FXI:C and FXI:ag, confirming previous findings that KNG1 loci influence FXI levels in plasma [25] [26] [27] . Our study adds detail to these observations; namely, that the effect of rs5030062 on FXI:ag can be explained by FXI:C. These findings support a previously proposed mechanism of KNG1-driven genetic regulation of FXI levels, in which the C allele of missense rs710446 (tagged by rs5030062) has been postulated to impact the functionality of HMWK by altering binding, which, in turn, could impact FXI:C, because FXI exists in complex with HMWK in circulation [26] . Both rs710446 and rs5030062 have histone enhancer markers in liver tissue [41] . A functional study would be required to explore the exact mechanism. In the present study, KNG1 SNV rs5030062 was also found to be associated with PK:ag, as was previously described [27] . However, in our analyses, this association disappeared following adjustment for HMWK:ag and was greatly reduced after adjustment for FXI levels, suggesting this association with PK:ag may be mediated by the association between rs5030062 and HMWK:ag and/or FXI:C.
We constructed haplotypes for F11 and KNG1 to assess joint effects between SNVs in moderate LD. The F11 haplotype occurring in 12.0% of control subjects, containing a T allele of rs2036914, T allele of rs2036914 and T allele of rs1593, had the largest joint effect on FXI:ag (b = À12.9; SE = 2.5; P = 0.002) and showed a slight association with IS (OR = 1.31; 95% CI, 0.80-2.16) and MI (OR = 1.24; 95% CI, 0.77-2.01). The KNG1 haplotype containing the minor allele (C) of rs5029980, major allele (T) of rs2304456 and minor allele (C) of rs5030062 (Haplotype 5) had a substantially higher impact on HMWK:ag levels (b = 25.2, SE = 3.4, P < 0.0001) compared with the reference than would be expected based on the sum of the effects of the two haplotypes containing only one minor allele each (Haplotype 2: T-T-C, b = 7.1; Haplotype 4: C-T-A, b = À0.5). Variant rs5029980 is a synonymous SNV, and although it does not change the amino acid sequence, it may still affect protein expression, conformation and even function [43] . SNV rs5029980 has both promoter histone markers and enhancer markers in liver tissue [41] . Both rs2304456 and rs710446, a SNV tagged by rs5030062, are known missense variants and may alter protein function. This KNG1 haplotype did not show an association with IS or MI (OR IS = 1.08, 95% CI 0.53-2.23; OR MI = 1.00, 95% CI 0.46-2.21), which may be because of low power, as this haplotype was carried by only 4.4% of control subjects.
Limitations
Even though our study was well powered to assess associations between single SNVs and multiple contact system traits, this study had limited power to test for associations of single SNVs with IS and MI risk, which is why we focused on haplotype combinations. We observed weak associations between F11 and KNG1 haplotypes containing relatively common variants and IS and MI.
Genotyping assays failed twice for KNG1 SNV rs530072 and it was not included in our analyses. The failed SNV is in moderate LD with one of our lead SNVs (rs5030062, r 2 = 0.79 in 1000 Genomes data), and was dropped in the conditional analysis of a previous finemapping study on FXI activity [25] , so it is unlikely we would have observed a strong effect on FXI levels by this SNV.
Remaining potential confounding factors in this study include population stratification and variants in linkage disequilibrium; as most women included in RATIO study were of European descent, population substructure was unlikely to be present, but the results can only be generalized to this population. Allelic frequencies and genomic distribution of polymorphisms were in Hardy-Weinberg equilibrium for all except five variants. This could be a result of chance, genotyping errors, or population admixture, although the latter is unlikely because four of five variants still tested below the 0.05 threshold after excluding non-Caucasians in a sensitivity analysis.
Since we chose SNVs that tag common variation in each gene, it is important to appreciate they may not be causal variants, rather just linked to causal variants. As in all case-control studies, survival bias could be a potential issue in the disease association analyses, and only control subjects were used for all other analyses. Furthermore, it has been demonstrated that adjusting genetic associations for correlated traits can bias effect estimates [44] ; however, because we did not observe any directional changes in the effect estimates in the conditional analyses, this is unlikely to have impacted our overall results.
Conclusion
Our study adds to current knowledge of how genetic variation, also in haplotype combinations, influences levels of contact system proteins and clarifies interdependencies via exploratory analyses. Our findings explain the differential influence of genetic variation on FXI activity and antigen levels and provide additional support for proposed hypotheses regarding mechanisms of action for downstream regulation of FXI levels via KNG1 loci. The newly observed associations between KLKB1 SNV rs4253243 and PK:ag, as well as KNG1 SNV rs5029980 and HMWK:ag, still require replication in other studies, and detailed research is needed to better understand which variants are causal and whether the haplotype associations with IS and MI can be confirmed in larger studies.
Addendum
The original design of the RATIO study was conceptualized by A. Algra and F. R. Rosendaal. This particular genetic sub-study was planned by C. Y. Vossen and B. 
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